ISRG - Intuitive Operating income before deduction of amortization

Public company logo of Intuitive (ISRG)

The Intuitive Surgical (ISRG) business model relies on recurring sales of services and components, which guarantees financial stability. EBITDA cash flow confirms this trend, with the 4539.36 mark serving as a current profit indicator. The company's revenues are independent of macroeconomic conditions, while strategic partnerships with clinics and physician training ensure technological leadership and surgical precision.

Intuitive Surgical (ISRG) - Profit before payment of interest, taxes and amortization from 11/23/2025 to 11/10/2026

Summary analytical data breakdowns for Intuitive (ISRG)

Fundamental company valuation:ISRG (Intuitive Corp)
Product sample of Intuitive Surgical, Inc.

This indicator captures real cash flow from operating activities, excluding accounting adjustments. Investors should interpret growth in this metric as confirmation of operational efficiency and financial stability. Analyzing EBITDA history allows for the identification of market volatility cycles and recession risks. For Intuitive Surgical (ISRG), this figure reflects the monetization of its technological superiority. A stable cash inflow is ensured by the global integration of complex surgical robots into clinic infrastructure.

Competitors of Intuitive Surgical (ISRG)

Income before deduction of interest, taxes and amortization DHR|Becton Dickinson & Co - Operating profit EBITDA|Operating income before deduction of amortization steris.com STE|West Pharmaceutical Services, Inc. (WST) - Profit before payment of interest, taxes and amortization|Operating profit before amortization BAX|Profit before payment of interest, taxes and amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Operating income before deduction of amortization|Operating profit before deduction of amortization TFX (Teleflex Incorporated)|Company profit before taxes, interest and amortization MMSI|Profit before payment of interest, taxes and amortization Envista NVST|Income before deduction of interest, taxes and amortization ICUI|XRAY: Operating profit before deduction of amortization|LMAT - Operating profit EBITDA|AtriCure, Inc. (ATRC) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization staar.com|NAGE (ChromaDex Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization ZimVie Inc ZIMV|Profit before payment of interest, taxes and amortization AngioDynamics Corp (ANGO)|Cerus Inc - Operating profit before amortization|Alpha Teknova, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization MGRM (monogramorthopedics.com)|STSS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InfuSystem Holdings INFU|UTMD: Operating profit EBITDA|KRMD - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Nyxoah S.A.|Operating profit before amortization MBOT (microbotmedical.com)|Operating profit before deduction of amortization PDEX (Pro-Dex)|Company profit before taxes, interest and amortization ZTEK|Elutia Corp - Operating profit before deduction of amortization|Operating profit EBITDA Milestone Scientific Corporation MLSS|NEXGEL, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Retractable Technologies RVP|HBIO (Harvard Bioscience) - Operating profit before deduction of amortization|FEMY: Company profit before taxes, interest and amortization|MHUA (Meihua Medical Technologies) - Operating profit EBITDA|Predictive Oncology Corp (POAI) - Operating income before deduction of amortization|Operating profit before deduction of amortization CJMB (Callan JMB Inc)|Profit before payment of interest, taxes and amortization ATRI (atrioncorp.com)|Operating profit EBITDA NURO (NeuroMetrix)